These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35576215)

  • 1. Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.
    Crespillo-Andújar C; Comeche B; Hamer DH; Arevalo-Rodriguez I; Alvarez-Díaz N; Zamora J; Pérez-Molina JA
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010386. PubMed ID: 35576215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis.
    Pérez-Molina JA; Pérez-Ayala A; Moreno S; Fernández-González MC; Zamora J; López-Velez R
    J Antimicrob Chemother; 2009 Dec; 64(6):1139-47. PubMed ID: 19819909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
    Ciapponi A; Barreira F; Perelli L; Bardach A; Gascón J; Molina I; Morillo C; Prado N; Riarte A; Torrico F; Ribeiro I; Villar JC; Sosa-Estani S
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008529. PubMed ID: 32804966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
    Torrico F; Gascón J; Barreira F; Blum B; Almeida IC; Alonso-Vega C; Barboza T; Bilbe G; Correia E; Garcia W; Ortiz L; Parrado R; Ramirez JC; Ribeiro I; Strub-Wourgaft N; Vaillant M; Sosa-Estani S;
    Lancet Infect Dis; 2021 Aug; 21(8):1129-1140. PubMed ID: 33836161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
    Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
    Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.
    Crespillo-Andújar C; Venanzi-Rullo E; López-Vélez R; Monge-Maillo B; Norman F; López-Polín A; Pérez-Molina JA
    Drug Saf; 2018 Nov; 41(11):1035-1048. PubMed ID: 30006773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
    Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A
    Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of benznidazole as a Chagas disease therapeutic.
    Caldas IS; Santos EG; Novaes RD
    Expert Opin Pharmacother; 2019 Oct; 20(15):1797-1807. PubMed ID: 31456439
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
    de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
    Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.
    Villar JC; Perez JG; Cortes OL; Riarte A; Pepper M; Marin-Neto JA; Guyatt GH
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003463. PubMed ID: 24867876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
    Cardoso CS; Ribeiro ALP; Oliveira CDL; Oliveira LC; Ferreira AM; Bierrenbach AL; Silva JLP; Colosimo EA; Ferreira JE; Lee TH; Busch MP; Reingold AL; Sabino EC
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006814. PubMed ID: 30383777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study.
    Jurado Medina L; Chassaing E; Ballering G; Gonzalez N; Marqué L; Liehl P; Pottel H; de Boer J; Chatelain E; Zrein M; Altcheh J
    Lancet Infect Dis; 2021 Aug; 21(8):1141-1150. PubMed ID: 33836157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review.
    Frade VP; Simões NS; Couto NRB; Sanches C; Oliveira CDL
    Rev Inst Med Trop Sao Paulo; 2020; 62():e52. PubMed ID: 32725057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.